Mar 19–22, 2028 | Sagamore Resort, Bolton Landing, NY, United States
Scientific Organizers:
Kendra K. Bence, Matthew R. Hayes, and Anna Secher
-
Scientific Organizers: Kendra K. Bence, Matthew R. Hayes, and Anna Secher
Kendra K. Bence, PhD
Eli Lilly and Company
Matthew R. Hayes, PhD
University of Pennsylvania
Anna Secher, PhD
Novo Nordisk A/S
***Meeting program subject to change.
Available Formats: = Livestream = In Person = On DemandMerchandise Options
Registration Options
Sunday, March 19, 2028
Monday, March 20, 2028
From Biology to Breakthroughs in Obesity Therapeutics
Multi-Receptor Potential of Incretin Therapies: Basic Biology of Obesity Therapeutics
Current Status and Potential of Incretin & Amylin-based Obesity Therapies
Biology of Amylin Receptor Agonists
Understanding the Mechanisms of Amylin-Based Obesity Therapeutics
Expanding Therapeutic Roles for GLP1-R Agonists Beyond Weight Loss: Cardiometabolic Protection
GLP1 Therapies and Addiction/Reward
Beyond Appetite: Incretins and the Neurobiology of Motivated Behavior
Tuesday, March 21, 2028
Dissociable Neural Circuits for Satiety and Nausea in the Control of Feeding
Neuroendocrine Circuits Regulating Body Weight: Implications for Obesity
Central Incretin Circuits: How GIP and GLP 1 Shape Feeding and Obesity
MC4R Pathways and Hypothalamic Obesity
Metabolic Adaptation and Energy Expenditure in Obesity
Adipose Innervation as a Driver of Energy Expenditure in Obesity
Ectopic Lipid, Mitochondrial Inefficiency, and the Regulation of Energy Expenditure in Obesity
Wednesday, March 22, 2028
Human Adipose Remodeling
Rewiring Adipose Tissue for Metabolic Health
Immune–Adipocyte Crosstalk and the Encoding of Obesogenic Memory
Optimizing the Fat–Muscle Equation: Therapeutic Strategies in Obesity
Beyond BMI: Quantifying Skeletal Muscle and Body Composition in Obesity
Muscle on the Spectrum: Obese Sarcopenia to Cachexia
Thursday, March 23, 2028
Subscribe for Updates